SR- BI and Tyrosine Kinase Inhibitors: A Novel Pathway for Atherosclerotic Cardiovascular Disease Therapeutic Development

Holly C. Sucharski-Argall, Sallie J. Jurs,Aaron D. Argall,Jordan L. Williams, Revati S. Dewali,Emma K. Dudley, Luke Comisford, Nondyce C. Gulik, Alaina A. Lah,Kristin I. Stanford,Peter J. Mohler,Sara N. Koenig

CIRCULATION（2023）

Cited 0|Views1

No score

Key words

HDL,Cholesterol-lowering drugs,Coronary artery disease,Dyslipidemia,Lipoproteins

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined